KDP Keurig Dr Pepper Inc

Dividend
3.63%
Previous close
$25.31
Est. 12 months change
+37.02%
Projected Price
$34.77

Profitability Metrics

Return on Equity (ROE)
8.36%
Return on Assets (ROA)
4.04%
Return on Invested Capital (ROIC)
5.95%
Weighted Average Cost of Capital (WACC)
5.19%
ROIC - WACC
0.76%
Updated : 2026-04-03 19:29 ET

Valuation Metrics

P/E Ratio
16.54
Forward P/E
11.08
PEG Ratio
1.84
Debt Current Ratio
0.64

Growth & Cash Flow

Gross Margin
54.20%
Operating Margin
22.18%
FCF Margin
9.01%
TTM Revenue Growth
10.54%
Projected 12M EPS Growth
49.34%

Price Change

Price % from 50 SMA
-9.70%
Price % from 200 SMA
-13.05%
6 Months
-1.67%
1 Year
-27.97%
2 Years
-18.14%
Click here to see the list of ETFs containing KDP as a top holding :Keurig Dr Pepper Inc ETFs

Analysis

Company Overview

Keurig Dr Pepper is a beverage company that produces, bottles, and distributes a broad range of hot and cold beverages, including coffee, soft drinks, and water. Sector: Consumer Staples.

Overview

Keurig Dr Pepper Inc (KDP) is an individual stock. The analysis below presents key financial metrics for the company, covering profitability, capital efficiency, valuation, margins, and growth.

Profitability & Capital Efficiency

On a capital return basis, ROIC is 5.95%, WACC is 5.19%, and the economic spread is 0.76%. On balance, the economic spread is positive but compressed — adequate for value preservation, less convincing for aggressive compounding. Supporting metrics show ROE at 8.36% and ROA at 4.04%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a company that is value-creative but with less room for execution slippage.

Valuation

On valuation, the company registers trailing P/E of 16.54, forward P/E of 11.08, PEG of 1.84. The spread between the two P/E figures is moderate, suggesting earnings are expected to improve gradually rather than accelerate sharply. The PEG reading here implies the market is pricing growth at roughly fair value — a setup where the investment case depends more on execution than on multiple expansion. A current ratio of 0.64 signals that short-term coverage is tighter than typical across the company. Taken together, the multiple and liquidity picture suggests a company that is priced for a constructive outcome — but where execution against earnings estimates will be the key determinant of whether that price is justified.

Margins & Cash Generation

Stripping to unit economics, gross margin sits at 54.20%, operating margin at 22.18%, and free cash flow margin at 9.01%. Gross margins are healthy, suggesting solid pricing power across the company. The operating margin reading is constructive, suggesting management teams are managing overhead costs effectively. At this FCF margin level, cash conversion is functional without being a standout feature of the company's quality profile. Read as a whole, the margin picture suggests a business with strengths in parts but no clear margin dominance end-to-end.

Growth & Forward Outlook

Connecting operational trends with market expectations, TTM revenue growth of 10.54% indicating steady top-line growth at the company level, while the estimated 12-month price change of 37.39%, where consensus targets imply substantial appreciation potential over the next 12 months. At 49.3%, the projected 12-month EPS growth rate is strong enough to be a primary driver of the forward investment case rather than a peripheral supporting detail. Operating momentum and analyst expectations are related but distinct — the former is backward-looking by nature, the latter inherently speculative. Against that backdrop, the more durable question is whether operating trends can be sustained long enough for analyst expectations to be validated. The estimated 12-month price change is based on analyst consensus price target estimates, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Strong Buy

The aggregate picture across capital efficiency, valuation, growth, and cash generation builds a compelling case.

This assessment is based solely on the quantitative metrics presented above and does not constitute financial advice. Investors should consider their own risk tolerance and conduct independent research before making investment decisions.